Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
- DOI
- 10.1136/rmdopen-2022-002876
- Published
- 2023 Mar
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2022-002876,
title = {Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.},
author = {Burska A and Rodríguez-Carrio J and Biesen R and Dik WA and Eloranta ML and Cavalli G and Visser M and Boumpas DT and Bertsias G and Wahren-Herlenius M and Rehwinkel J and Frémond ML and Crow MK and Ronnblom L and Conaghan PG and Versnel M and Vital E},
year = {2023},
journal = {RMD open},
doi = {10.1136/rmdopen-2022-002876},
url = {https://doi.org/10.1136/rmdopen-2022-002876}
}RIS
TY - JOUR TI - Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. AU - Burska A AU - Rodríguez-Carrio J AU - Biesen R AU - Dik WA AU - Eloranta ML AU - Cavalli G AU - Visser M AU - Boumpas DT AU - Bertsias G AU - Wahren-Herlenius M AU - Rehwinkel J AU - Frémond ML AU - Crow MK AU - Ronnblom L AU - Conaghan PG AU - Versnel M AU - Vital E PY - 2023 JO - RMD open DO - 10.1136/rmdopen-2022-002876 UR - https://doi.org/10.1136/rmdopen-2022-002876 ER -
APA
A, B., J, R., R, B., WA, D., ML, E., G, C., M, V., DT, B., G, B., M, W., J, R., ML, F., MK, C., L, R., PG, C., M, V., & E, V. (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.. RMD open. https://doi.org/10.1136/rmdopen-2022-002876